EMERGING CORONAVIRUSES IN NEOTROPICAL PRIMATES: A NEW THREAT?
Resumen
Anthropogenic activities are the main reason for the current alarming conservation status of non-human primates (NHP) worldwide, and also lead to habitat-sharing, facilitating human-NHP (interspecific) viral transmission. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the ongoing COVID-19 pandemic, is well-known for its large genome plasticity and spike proteins (S proteins) highly adaptable to human receptor angiotensin-converting enzyme-2 (ACE2). NHP have been used as models for clinical, diagnostic, and therapeutic studies on SARS-CoV-2 and their correlates. However, the lack of systematic sanitary surveillance in NHP in the Neotropics, as well as the limited capacity to detect infections in their populations, challenge the implementation of consistent epidemiological connections regarding the potential interspecific transmission in the natural environment. Although the natural cross-transmission of SARS-CoV-2 between humans and NHP has not been demonstrated, the global spread of the virus represents a potential threat. Thus, establishing preventive, surveillance, and control measures for viruses of the family Coronaviridae in Neotropical NHP populations is crucial for their conservation.
Descargas
Citas
AFELT, A.; DEVAUX, C.; SERRA-COBO, J.; FRUTOS, R. Bats, Bat-Borne Viruses, and Environmental Changes. Bats, 2018.
ANDERSEN, K.G.; RAMBAUT, A.; LIPKIN, W.I.; HOLMES, E.C.; GARRY, R.F. The proximal origin of SARS-CoV-2. Nature medicine, v.26, p.450-452, 2020.
ARABI, Y.M.; HAJEER, A.H.; LUKE, T.; RAVIPRAKASH, K.; BALKHY, H.; JOHANI, S.; AL-DAWOOD, A.; AL-QAHTANI, S.; AL-OMARI, A.; AL-HAMEED, F.; HAYDEN, F.G.; FOWLER, R.; BOUCHAMA, A.; SHINDO, N.; AL-KHAIRY, K.; CARSON, G.; TAHA, Y.; SADAT, M.; ALAHMADI, M. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia. Emerging Infectious Diseases, v.22, p.1554–1561, 2016.
AZHAR, E.I.; EL-KAFRAWY, S.A.; FARRAJ, S.A.; HASSAN, A.M.; AL-SAEED, M.S.; HASHEM, A.M.; MADANI, T.A. Evidence for camel-to-human transmission of MERS coronavirus. New England Journal Medicine, v.370, p.2499–2505, 2014. <10.1056/NEJMoa1401505>.
CAPITANIO, J.P. Social Processes and Disease in Nonhuman Primates: Introduction to the Special Section. American Journal of Primatology, v.74, p.491–496, 2012.
CARRION, R.; PATTERSON, J.L. An animal model that reflects human disease: The common marmoset (Callithrix jacchus). Current Opinion in Virology, v.2, p.357–362, 2012.
CASAGRANDE, R.A.; PANNUTI, C.S.; KANAMURA, C.; FREIRE, W.S.; GRESPAN, A.; MATUSHIMA, E.R. Fatal Human herpesvirus 1 (HHV-1) infection in captive marmosets (Callithrix jacchus and Callithrix penicillata) in Brazil: Clinical and pathological characterization. Pesquisa Veterinaria Brasileira, v.34, p.1109–1114, 2014.
CHAN, M. “World now at start of 2009 influenza pandemic: Statement to the press by WHO director-general,” 11 June 2009. 2009. Available at:
CHAPMAN, C.A.; BONNELL, T.R.; OMEJA, P.A.; TWINOMUGISHA, D. Are Primates Ecosystem Engineers? International Journal of Primatology, v.34, p.1–14, 2013.
CHEN, E.C.; YAGI, S.; KELLY, K.R.; MENDOZA, S.P.; MANINGER, N.; ROSENTHAL, A.; SPINNER, A.; BALES, K.L.; SCHNURR, D.P.; LERCHE, N.W.; CHIU, C.Y. Cross-species transmission of a novel adenovirus associated with a fulminant pneumonia outbreak in a new world monkey colony. PLoS Pathogens, v.7, 2011.
CONTINI, C.; DI NUZZO, M.; BARP, N.; BONAZZA, A.; DE GIORGIO, R.; TOGNON, M.; RUBINO, S. The novel zoonotic COVID-19 pandemic: An expected global health concern. The Journal of Infection in Developing Countries, v.14, p.254-264, 2020.
COOPER, N.; NUNN, C.L. Identifying future zoonotic disease threats Where are the gaps in our understanding of primate infectious. Evolution, Medicine, and Public Health, p.27–36, 2013.
CORMAN, V.M.; MUTH, D.; NIEMEYER, D.; DROSTEN, C. Hosts and sources of endemic human coronaviruses. Advances in Virus Research, v.100, p. 163-188, 2018.
CORMIER, L. A Preliminary Review of Neotropical Primates in the Subsistence and Symbolism of Indigenous Lowland South American Peoples. Ecological and Environmental Anthropology, v.2, p.14–32, 2006.
CORTI, D.; ZHAO, J.; PEDOTTI, M.; SIMONELLI, L.; AGNIHOTHRAM, S.; FETT, C.; FERNANDEZ-RODRIGUEZ, B.; FOGLIERINI, M.; AGATIC, G.; VANZETTA, F.; GOPAL, R.; LANGRISH, C.J.; BARRETT, N.A.; SALLUSTO, F.; BARIC, R.S.; VARANI, L.; ZAMBON, M.; PERLMAN, S.; LANZAVECCHIA, A. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proceedings of the National Academy of Sciences of the United States of America, v.112, p.10473–10478, 2015.
CRACKOWER, M.A.; SARAO, R.; OLIVEIRA-DOS-SANTOS, A.J.; DA COSTA, J.; ZHANG, L. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature, v.417, p.822–828, 2002.
CUI, J.; LI, F.; SHI, Z. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, v.17, p.181-192, 2019.
DASZAK, P.; CUNNINGHAM, A.A.; HYATT, A.D. Emerging infectious diseases of wildlife - Threats to biodiversity and human health. Science, v.287, p.443–449, 2000.
DE WIT, E.; FELDMANN, F.; HORNE, E.; OKUMURA, A.; CAMERONI, E.; HADDOCK, E.; SATURDAY, G.; SCOTT, D.; GOPAL, R.; ZAMBON, M.; CORTI, D.; FELDMANN, H. Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset. Antiviral Research, v.163, p.70–74, 2019.
DE WIT, E.; FELDMANN, F.; OKUMURA, A.; HORNE, E.; HADDOCK, E.; SATURDAY, G.; SCOTT, D.; ERLANDSON, K.J.; STAHL, N.; LIPSICH, L.; KYRATSOUS, C.A.; FELDMANN, H. Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets. Antiviral Research, v.156, p.64–71, 2018.
DELMAS, B.; GELFI, J.; KUT, E.; SJÖSTRÖM, H.; NOREN, O.; LAUDE, H. Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site. Journal of Virology, v.68, p.5216–5224, 1994.
DEVAUX, C.A.; MEDIANNIKOV, O.; MEDKOUR, H.; RAOULT, D. Infectious Disease Risk Across the Growing Human-Non Human Primate Interface: A Review of the Evidence. Frontiers in Public Health, v.7, p.1–22, 2019.
ESTRADA, A.; GARBER, P.A.; MITTERMEIER, R.A.; WICH, S.; GOUVEIA, S.; DOBROVOLSKI, R.; NEKARIS, K.A.I.; NIJMAN, V.; RYLANDS, A.B.; MAISELS, F.; WILLIAMSON, E.A.; BICCA-MARQUES, J.; FUENTES, A.; JERUSALINSKY, L.; JOHNSON, S.; DE MELO, F.R.; OLIVEIRA, L.; SCHWITZER, C.; ROOS, C.; CHEYNE, S.M.; KIERULFF, M.C.M.; RAHARIVOLOLONA, B.; TALEBI, M.; RATSIMBAZAFY, J.; SUPRIATNA, J.; BOONRATANA, R.; WEDANA, M.; SETIAWAN, A. Primates in peril: The significance of Brazil, Madagascar, Indonesia and the Democratic Republic of the Congo for global primate conservation. PeerJ, v.2018, p.1–57, 2018.
ESTRADA, A.; GARBER, P.A.; RYLANDS, A.B.; ROOS, C.; FERNANDEZ-DUQUE, E.; DI FIORE, A.; NEKARIS, K.A.; NIJMAN, V.; HEYMANN, E.W.; LAMBERT, J.E.; ROVERO, F.; BARELLI, C.; BAOGUO, L. Impending extinction crisis of the world ’ s primates : Why primates matter. Science Advances, v.3, p.e1600946, 2017.
ESTRADA, A.; RABOY, B.E.; OLIVEIRA, L.C. Agroecosystems and Primate Conservation in the Tropics: A Review. American Journal of Primatology, v.74, p.696–711, 2012.
FALZARANO, D.; WIT, E. DE; RASMUSSEN, A.L.; FELDMANN, F.; OKUMURA, A.; SCOTT, D.P.; BRINING, D.; BUSHMAKER, T.; MARTELLARO, C.; BASELER, L.; BENECKE, A.G.; KATZE, M.G.; MUNSTER, V.J.; FELDMANN, H. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nature Medicine, v.19, p.1313–1317, 2013.
FORNI, D.; CAGLIANI, R.; CLERICI, M.; SIRONI, M. Molecular evolution of human coronavirus genomes. Trends in Microbiology, v.25, p.35-48, 2017. <10.1016/j.tim.2016.09.001>.
FOUCHIER, R.A.M.; KUIKEN, T.; SCHUTTEN, M.; VAN AMERONGEN, G.; VAN DOORNUM, G.J.J.; VAN DEN HOOGEN, B.G.; PEIRIS, M.; LIM, W.; STÖHR, K.; OSTERHAUS, A.D.M.E. Koch’s postulates fulfilled for SARS virus. Nature, v.423, p.240, 2003.
FUASHI, N.A.; EKANE, M.M.; JACQUELINE, E.; ZEH, F.A. An evaluation of poaching and bushmeat off takes in the Ebo Forest Reserve (EFR), Littoral Region, Cameroon. Journal of Ecology and The Natural Environment, v.11, p.14-25, 2019.
GHEBREYESUS, T.A.; SWAMINATHAN, S. Scientists are sprinting to outpace the novel coronavirus. The Lancet, v.395, p.762–764, 2020.
GORBALENYA, A.E.; BAKER, S.C.; BARIC, R.S. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, v.5, p.536–544, 2020.
GRAHAM, R.L.; DONALDSON, E.F.; BARIC, R.S. A decade after SARS: Strategies for controlling emerging coronaviruses. Nature Reviews Microbiology, v.11, p.836–848, 2013.
HAAGMANS, B.L.; OSTERHAUS, A.D.M.E. Nonhuman primate models for SARS. PLoS Medicine, v.3, p.598–599, 2006.
HOFFMANN, M.; KLEINE-WEBER, H.; SCHROEDER, S.; KRUGER, N.; HERRLER, T.; ERICHSEN, S.; SCHIERGENS, T.S.; HERRLER, G.; WU, N.H.; NITSCHE, A.; MULLER, M.A.; DROSTEN, C.; POHLMANN, S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, v.181, p. 271-280, 2020.
ICTV (The International Committee on Taxonomy of Viruses). Virus Taxonomy: 2019 Release EC 51, Berlin, Germany, July 2019
Email ratification March 2020 (MSL #35). 2020. Available at:
JERUSALINSKY, L.; AZEVEDO, R.B. DE; GORDO, M. Plano de ação nacional para a conservação do Sauim-de-coleira. Brasília: Instituto Chico Mendes de Conservação da Biodiversidade, Icmbio, 2017. 207p.
JOHNSON, R.F.; BAGCI, U.; KEITH, L.; TANG, X.; MOLLURA, D.J.; ZEITLIN, L.; QIN, J.; HUZELLA, L.; BARTOS, C.J.; BOHOROVA, N.; BOHOROV, O.; GOODMAN, C.; KIM, D.H.; PAULTY, M.H.; VELASCO, J.; WHALEY, K.J.; JOHNSON, J.C.; PETTITT, J.; ORK, B.L.; SOLOMON, J.; OBERLANDER, N.; ZHU, Q.; SUN, J.; HOLBROOK, M.R.; OLINGER, G.G.; BARIC, R.S.; HENSLEY, L.E.; JAHRLING, P.B.; MARASCO, W.A. 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012. Virology, v.490, p.49–58, 2016.
KAHN, J.S.; MCINTOSH, K. History and recent advances in coronavirus discovery. The Pediatric Infectious Disease Journal, v.24, p.S223-S227, 2005.
KAZABA, P.K. “Non-protected” primates as bushmeat, pets and pests in southeastern Democratic Republic of Congo. Journal of Threatened Taxa, v.11, p.13251–13260, 2019.
LAWLER, J.V.; ENDY, T.P.; HENSLEY, L.E.; GARRISON, A.; FRITZ, E.A.; LESAR, M.; BARIC, R.S.; KULESH, D.A.; NORWOOD, D.A.; WASIELOSKI, L.P.; ULRICH, M.P.; SLEZAK, T.R.; VITALIS, E.; HUGGINS, J.W.; JAHRLING, P.B.; PARAGAS, J. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Medicine, v.3, p.677–686, 2006.
LI, W.; MOORE, M.J.; VASILIEVA, N.; SUI, J.; WONG, S.K.; BERNE, M.A.; SOMASUNDARAN, M.; SULLIVAN, J.L.; LUZURIAGA, K.; GREENOUGH, T.C.; CHOE, H.; FARZAN, M. Angiotensin-converting enzyme 2: A functional receptor for SARS coronavirus. Nature, v.426, p.450–454, 2003.
LONGA, C.S.; BRUNO, S.F.; PIRES, A.R.; ROMIJN, P.C.; KIMURA, L.S.; COSTA, C.H. Human Herpesvirus 1 in Wild Marmosets, Brazil, 2008. Emerging Infectious Diseases, v.17, p.1308–1309, 2011.
LOWENSTINE, L.J. Measles Virus Infection, Nonhuman Primates. In: JONES, T.C.; MOHR, U.; HUNT, R.D. Nonhuman Primates I. 1.ed. Washington: Springer-Verlag Berlin Heidelberg, 1993. v.1, p.108–118.
MAIR-JENKINS, J.; SAAVEDRA-CAMPOS, M.; BAILLIE, J.K.; CLEARY, P.; KHAW, F.M.; LIM, W.S.; MAKKI, S.; ROONEY, K.D.; NGUYEN-VAN-TAM, J.S.; BECK, C.R. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. Journal of Infectious Diseases, v.211, p.80–90, 2015.
MASTERS, P.S.; PERLMAN, S. Coronaviridae. In: Knipe, D.M.; Howley, P. Fields Virology. 6.ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2013. p.825-858.
MCAULIFFE, J.; VOGEL, L.; ROBERTS, A.; FAHLE, G.; FISCHER, S.; SHIEH, W.J.; BUTLER, E.; ZAKI, S.; CLAIRE, M. ST.; MURPHY, B.; SUBBARAO, K. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology, v.330, p.8–15, 2004.
MCINTOSH, K. Coronaviruses: a comparative review. Current Topics in Microbiology and Immunology, v. 63, p. 85-129, 1974.
MÜLLER, M.A; RAJ, V.S.; MUTH, D. Human Coronavirus EMC Does Not Require the SARS-Coronavirus. mBio, v.3, p.1–5, 2012.
MUNSTER, V.J.; DE WIT, E.; FELDMANN, H. Pneumonia from Human Coronavirus in a Macaque Model. The New England Journal of Medicine, v.18, p.1–7, 2013.
NAGATA, N.; IWATA, N.; HASEGAWA, H.; SATO, Y.; MORIKAWA, S.; SAIJO, M.; ITAMURA, S.; SAITO, T.; AMI, Y.; ODAGIRI, T.; TASHIRO, M.; SATA, T. Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. International Journal of Experimental Pathology, v.88, p.403–414, 2007.
NORCONK, M.A. Commentaries on field-laboratory collaborations in primatology: Introduction to a special section of the American Journal of Primatology. American Journal of Primatology, v.81, p.1–3, 2019.
PERES, C.A.; EMILIO, T.; SCHIETTI, J.; DESMOULIÈRE, S.J.M.; LEVI, T. Dispersal limitation induces long-term biomass collapse in overhunted Amazonian forests. Proceedings of the National Academy of Sciences, v.113, p.892–897, 2016.
PETROSILLO, N.; VICECONTE, G.; ERGONUL, O.; IPPOLITO, G.; PETERSEN, E. COVID-19, SARS and MERS: are they closely related? Clinical Microbiology and Infection, v.26, p.729–734, 2020.
POSSAS, C.; LOURENÇO-DE-OLIVEIRA, R.; TAUIL, P.L.; PINHEIRO, F.D.P.; PISSINATTI, A.; DA CUNHA, R.V.; FREIRE, M.; MARTINS, R.M.; HOMMA, A. Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation. Memorias do Instituto Oswaldo Cruz, v.113, p.e180278, 2018.
ROCHA, V.C.M.; IKUTA, C.Y.; GOMES, M.S.; QUAGLIA, F.; MATUSHIMA, E.R.; NETO, J.S.F. Isolation of Mycobacterium tuberculosis from captive Ateles paniscus. Vector-Borne and Zoonotic Diseases, v.11, p.593–594, 2011.
ROSENBAUM, M.; MENDOZA, P.; GHERSI, B.M.; WILBUR, A.K.; PEREZ-BRUMER, A.; CAVERO YONG, N.; KASPER, M.R.; MONTANO, S.; ZUNT, J.R.; JONES-ENGEL, L. Detection of Mycobacterium tuberculosis Complex in New World Monkeys in Peru. EcoHealth, v.12, p.288–297, 2015.
ROWE, T.; GAO, G.; HOGAN, R.J.; CRYSTAL, R.G.; VOSS, T.G.; GRANT, R.L.; BELL, P.; KOBINGER, G.P.; WIVEL, N.A.; WILSON, J.M. Macaque Model for Severe Acute Respiratory Syndrome. Journal of Virology, v.78, p.11401–11404, 2004.
SCHWITZER, C.; MITTERMEIER, R.A.; RYLANDS, A.B.; CHIOZZA, F.; WILLIAMSON, E.A.; MACFIE, E.J.; WALLIS, J.; COTTON, A. Primates in Peril The world’s 25 most endangered primates 2018-2020. Bristol: IUCN SSC Primate Specialist Group (PSG), International Primatological Society (IPS), Global Wildlife Conservation (GWC), Bristol Zoological Society (BZS), 2019. 129p.
SHANEE, N.; MENDOZA, A.P.; SHANEE, S. Diagnostic overview of the illegal trade in primates and law enforcement in Peru. American Journal of Primatology, v.79, p.1–12, 2017.
SMITH, K.M.; ANTHONY, S.J.; SWITZER, W.M.; EPSTEIN, J.H.; SEIMON, T.; JIA, H.; SANCHEZ, M.D.; HUYNH, T.T.; GALLAND, G.G.; SHAPIRO, S.E.; SLEEMAN, J.M.; MCALOOSE, D.; STUCHIN, M.; AMATO, G.; KOLOKOTRONIS, S.O.; LIPKIN, W.I.; KARESH, W.B.; DASZAK, P.; MARANO, N. Zoonotic viruses associated with illegally imported wildlife products. PLoS ONE, v.7, 2012.
SMITH, R.D. Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Social Science & Medicine, v.63, p. 3113–3123, 2006.
SMITS, S.L.; VAN DEN BRAND, J.M.A.; DE LANG, A.; LEIJTEN, L.M.E.; VAN IJCKEN, W.F.; VAN AMERONGEN, G.; OSTERHAUS, A.D.M.E.; ANDEWEG, A.C.; HAAGMANS, B.L. Distinct Severe Acute Respiratory Syndrome Coronavirus-induced acute lung injury pathways in two different nonhuman primate species. Journal of Virology, v.85, p.4234–4245, 2011.
SMITS, S.L.; DE LANG, A.; VAN DEN BRAND, J.M.A.; LEIJTEN, L.M.; VAN IJCKEN, W.F.; EIJKEMANS, M.J.C.; VAN AMERONGEN, G.; KUIKEN, T.; ANDEWEG, A.C.; OSTERHAUS, A.D.M.E.; HAAGMANS, B.L. Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathogens, v.6, p. e1000756, 2010.
SONG, Z.; XU, Y.; BAO, L.; ZHANG, L.; YU, P.; QU, Y.; QIN, C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, v.11, p.59, 2019.
SUBBARAO, K.; ROBERTS, A. Is there an ideal animal model for SARS? Trends in Microbiology, v.14, p.299–303, 2006.
SUTTON, T.C.; SUBBARAO, K. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus. Virology, v.479–480, p.247–258, 2015.
TERZIAN, A.C.B.; ZINI, N.; SACCHETTO, L.; ROCHA, R.F.; PARRA, M.C.P.; DEL SARTO, J.L.; DIAS, A.C.F.; COUTINHO, F.; RAYRA, J.; SILVA, R.A. DA; COSTA, V.V.; FERNANDES, N.C.C.D.A.; RÉSSIO, R.; DÍAZ-DELGADO, J.; GUERRA, J.; CUNHA, M.S.; CATÃO-DIAS, J.L.; BITTAR, C.; REIS, A.F.N.; SANTOS, I.N.P. DOS; FERREIRA, A.C.M.; CRUZ, L.E.A.A.; RAHAL, P.; ULLMANN, L.; MALOSSI, C.; DE ARAÚJO, J.P.; WIDEN, S.; DE REZENDE, I.M.; MELLO, É.; PACCA, C.C.; KROON, E.G.; TRINDADE, G.; DRUMOND, B.; CHIARAVALLOTI-NETO, F.; VASILAKIS, N.; TEIXEIRA, M.M.; NOGUEIRA, M.L. Evidence of natural Zika virus infection in neotropical non-human primates in Brazil. Scientific Reports, v.8, p.1–15, 2018.
TILMAN, D.; CLARK, M. Global diets link environmental sustainability and human health. Nature, v.515, p.518–522, 2014.
UNITED NATIONS. Department of Economic and Social Affairs. Everyone Included: Social Impact of COVID-19. 2020. Available at:
VAN DER HOEK, L.; PYRC, K; JEBBINK, M.F.; VERMEULEN-OOST, W.; BERKHOUT, R.J.; WOLTHERS, K.C.; WERTHEIM-VAN DILLEN, P. M.; KAANDORP, J.; SPAARGAREN, J.; BERKHOUT, B. Identification of a new human coronavirus. Nature Medicine, v.10, p.368–373, 2004.
VAN DOREMALEN, N.; FALZARANO, D.; YING, T.; DE WIT, E.; BUSHMAKER, T.; FELDMANN, F.; OKUMURA, A.; WANG, Y.; SCOTT, D.P.; HANLEY, P.W.; FELDMANN, H.; DIMITROV, D.S.; MUNSTER, V.J. Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Research, v.143, p.30–37, 2017.
VERGARA-ALERT, J.; VIDAL, E.; BENSAID, A.; SEGALÉS, J. Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus. One Health, v.3, p.34–40, 2017.
WANG, X.; XU, W.; HU, G.; XIA, S.; SUN, Z.; LIU, Z.; XIE, Y.; ZHANG, R.; JIANG, S.; LU, L. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cellular & Molecular Immunology, p.1–3, 2020.
WHO (World Health Organization). Coronavirus disease (COVID-19) Situation Report - 150. 2020a. Available at:
WHO (World Health Organization) 2020 June 4. Sutation Report about Deaths from COVID-19 in the World. 2020b. Disponível em:
WOO, P.C.; LAU, S.K.; CHU, C.M.; CHAN, K.H.; TSOI, H.W.; HUANG, Y.; WONG, B.H.; POON, R.W.; CAI, J.J.; LUK, W.K. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. Journal of Virology, v.79, p.884–895, 2005.
YE, Z.-W.; YUAN, S.; YUEN, K.-S.; FUNG, S.-Y.; CHAN, C.-P.; JIN, D.-Y. Zoonotic origins of human coronaviruses. International Journal of Biological Sciences, v.16, p.1686–1697, 2020.
ZHAO, S.; LIN, Q.; RAN, J.; MUSA, S. S.; YANG, G.; WANG, W. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases. v. 92, p.214-217, 2002.